161 related articles for article (PubMed ID: 26725358)
1. [Extranodal natural killer/T-cell lymphoma, nasal type developing central nervous system and epididymis involvement immediately after concurrent chemoradiotherapy].
Sasaki Y; Yonezawa A; Kinoshita Y; Kitagawa T; Mori M; Onaka T; Imada K
Rinsho Ketsueki; 2015 Dec; 56(12):2472-6. PubMed ID: 26725358
[TBL] [Abstract][Full Text] [Related]
2. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
[TBL] [Abstract][Full Text] [Related]
4. Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.
Makita S; Tobinai K
Hematol Oncol Clin North Am; 2017 Apr; 31(2):239-253. PubMed ID: 28340876
[TBL] [Abstract][Full Text] [Related]
5. The simultaneous appearance of a nasal natural killer-cell lymphoma and acute myelogenous leukemia.
Van Crombrugge L; De Vos G; Vanclooster C; Lemmerling M; Kerre T
B-ENT; 2012; 8(1):49-52. PubMed ID: 22545391
[TBL] [Abstract][Full Text] [Related]
6. Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Michot JM; Mazeron R; Danu A; Lazarovici J; Ghez D; Antosikova A; Willekens C; Chamseddine AN; Minard V; Dartigues P; Bosq J; Carde P; Koscielny S; De Botton S; Ferme C; Girinsky T; Ribrag V
Eur J Cancer; 2015 Nov; 51(16):2386-95. PubMed ID: 26254810
[TBL] [Abstract][Full Text] [Related]
7. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M; Suzuki R; Oguchi M
Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
[TBL] [Abstract][Full Text] [Related]
8. Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature.
Wang X; Gong Z; Li SX; Yan W; Song Y
BMC Urol; 2017 Sep; 17(1):77. PubMed ID: 28874193
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Kim SJ; Kim K; Kim BS; Kim CY; Suh C; Huh J; Lee SW; Kim JS; Cho J; Lee GW; Kang KM; Eom HS; Pyo HR; Ahn YC; Ko YH; Kim WS
J Clin Oncol; 2009 Dec; 27(35):6027-32. PubMed ID: 19884539
[TBL] [Abstract][Full Text] [Related]
10. Extranodal natural killer/T-cell lymphoma, nasal-type.
Chorianopoulos D; Samitas K; Vittorakis S; Kiriazi V; Rondoyianni D; Tsaousis G; Skoutelis A
Skinmed; 2010; 8(1):56-8. PubMed ID: 20839428
[TBL] [Abstract][Full Text] [Related]
11. A case of nasal natural killer/T lymphoma revealed by repeated deep neck abscess.
Baba S; Baba M; Hagisawa M; Kimura M; Nakashima M; Nakahara H
Am J Otolaryngol; 2009; 30(4):269-72. PubMed ID: 19563940
[TBL] [Abstract][Full Text] [Related]
12. MRI appearances of stage IE/IIE extranodal NK/T-cell lymphoma, nasal type, in the upper aerodigestive tract.
Gu Y; Wu B; Zhang Y; Guo Y; Peng W
Eur Rev Med Pharmacol Sci; 2014; 18(3):404-12. PubMed ID: 24563442
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
[TBL] [Abstract][Full Text] [Related]
14. [Relapse in the nasal cavity of a patient with extranodal NK/T-cell lymphoma initially presenting as plantar subcutaneous tumor].
Sakaguchi H; Miyazaki K; Tono Y; Fujieda A; Nakamori Y; Mizutani M; Sekine T; Shibazaki T; Oka K; Katou K; Monma F; Yamaguchi M; Masuya M; Katayama N
Rinsho Ketsueki; 2015 Aug; 56(8):1076-81. PubMed ID: 26345570
[TBL] [Abstract][Full Text] [Related]
15. Extranodal natural killer/T-cell lymphoma, nasal type: clinical and computed tomography findings in the head and neck region.
Hung LY; Chang PH; Lee TJ; Hsu YP; Chen YW; Fu CH; Huang CC
Laryngoscope; 2012 Dec; 122(12):2632-9. PubMed ID: 22965840
[TBL] [Abstract][Full Text] [Related]
16. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
17. [Long-term remission of a nasal NK/T-cell lymphoma patient with massive involvement of the orbita and liver dysfunction].
Monma F; Ueno S; Yamaguchi M; Tawara I; Miyazaki K; Nishii K; Nakase K; Katayama N
Rinsho Ketsueki; 2009 Jan; 50(1):44-8. PubMed ID: 19225229
[TBL] [Abstract][Full Text] [Related]
18. [Nasal type natural killer/T cell lymphoma: case series and literature review].
Düzlü M; Ant A; Tutar H; Karamert R; Şahin M; Sayar E; Cesur N
Kulak Burun Bogaz Ihtis Derg; 2016; 26(4):241-7. PubMed ID: 27405082
[TBL] [Abstract][Full Text] [Related]
19. Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Oh D; Ahn YC; Kim SJ; Kim WS; Ko YH
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):677-83. PubMed ID: 26461010
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
Yamaguchi M; Kwong YL; Kim WS; Maeda Y; Hashimoto C; Suh C; Izutsu K; Ishida F; Isobe Y; Sueoka E; Suzumiya J; Kodama T; Kimura H; Hyo R; Nakamura S; Oshimi K; Suzuki R
J Clin Oncol; 2011 Nov; 29(33):4410-6. PubMed ID: 21990393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
